福泰制药Vertex Pharmaceuticals Inc. (VRTX) 2016年10-K年度报告「NASDAQ」.pdf

1、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 02/23/17 for the Period Ending 12/31/16 Address50 NORTHERN AVENUEBOSTON,MA 02210Telephone6173416393CIK0000875320SymbolVRTXSIC Code2834-Pharmaceutical PreparationsIndustryBiotechnology&Medical ResearchSectorHealthcareFiscal Year12/31http:/www

2、.edgar- Copyright 2017,EDGAR Online,Inc.All Rights Reserved.Distribution and use of this document restricted under EDGAR Online,Inc.Terms of Use.UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON,D.C.20549_FORM 10-KxANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT O

3、F 1934For the Fiscal Year Ended December 31,2016oroTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from to Commission file number 000-19319_Vertex Pharmaceuticals Incorporated(Exactnameofregistrantasspecifiedinitscharter)Massachusetts0

4、4-3039129(Stateorotherjurisdictionofincorporationororganization)(I.R.S.EmployerIdentificationNo.)50 Northern Avenue,Boston,Massachusetts02210(Addressofprincipalexecutiveoffices)(ZipCode)Registrantstelephonenumber,includingareacode(617)341-6100_SecuritiesregisteredpursuanttoSection12(b)oftheExchangeA

5、ct:Title of Each ClassName of Each Exchange on Which RegisteredCommonStock,$0.01ParValuePerShareTheNASDAQGlobalSelectMarketSecuritiesregisteredpursuanttoSection12(g)oftheExchangeAct:None_Indicatebycheckmarkiftheregistrantisawell-knownseasonedissuer,asdefinedinRule405oftheSecuritiesAct.YesxNooIndicat

6、ebycheckmarkiftheregistrantisnotrequiredtofilereportspursuanttoSection13orSection15(d)oftheExchangeAct.YesoNoxIndicatebycheckmarkwhethertheregistrant:(1)hasfiledallreportsrequiredtobefiledbySection13or15(d)oftheSecuritiesExchangeActof1934duringthepreceding12months(orforsuchshorterperiodthattheregist